GlassScriptPhysician profile
Adriana P Sanchez
NPI 1205127636
$10,992.88
in general payments reported to CMS, 2019-2025
37 companies · $2,819 in 2025
The $2,819 reported for 2025 was more than what 97% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,954 · 2022: $2,083 · 2023: $1,789 · 2024: $2,348 · 2025: $2,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,955.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,514.84 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,876.76 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,029.85 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $635.51 | 2023-2025 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $541.67 | 2021-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $359.10 | 2021-2025 | Delstrigo, Pifeltro, Dificid |
| Janssen Biotech, INC. | $334.65 | 2022-2023 | Symtuza |
| Philips North America LLC | $315.94 | 2022-2025 | Patient Interface Software, (Ak6) Vest Therapy |
| Emd Serono, INC. | $286.40 | 2021-2024 | Serostim |
| Insmed, INC. | $236.42 | 2022-2025 | Arikayce, Brinsupri |
| Verona Pharma, INC. | $179.93 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $166.94 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $165.08 | 2021-2025 | |
| Harmony Biosciences LLC | $161.68 | 2022-2024 | |
| Genzyme Corporation | $158.04 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theratechnologies INC. | $145.62 | 2021-2022 | |
| Baxter Healthcare | $140.15 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Advanced Respiratory, INC | $95.63 | 2021 | |
| Abbvie INC. | $65.30 | 2022-2023 | |
| Grifols USA, LLC | $64.77 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $60.89 | 2021 | |
| Sanofi-Aventis U.S. LLC | $54.99 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $54.07 | 2024-2025 | Dupixent |
| Electromed, INC. | $50.92 | 2025 | Smartvest |
| Napo Pharmaceuticals INC | $47.62 | 2023 | Mytesi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.88 | 2021-2022 | |
| Boston Scientific Corporation | $26.34 | 2022 | |
| 180 Medical, INC. | $22.90 | 2022 | |
| Mallinckrodt Hospital Products INC. | $21.96 | 2025 | Acthar |
| Astellas Pharma US INC | $21.01 | 2023 | Cresemba |
| Liquidia Technologies, INC. | $20.00 | 2025 | Yutrepia |
| Inogen, INC. | $19.98 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Takeda Pharmaceuticals U.S.A., INC. | $19.60 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $18.75 | 2025 | Neffy |
| Pulmonx Corporation | $18.69 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Gilead Sciences, INC. | $16.60 | 2022 | |
| United Therapeutics Corporation | $14.40 | 2024 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adriana Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.